Ocular Therapeutix (OCUL) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Ocular Therapeutix

· OCUL

Dashboard

Financials

Ratios

Transcripts

Valuation

Statistics

1.728 B

-2.54%

Ocular Therapeutix (OCUL) Company Statistics | The Fly

General

Market Cap: $1.73B
Enterprise Value: $1.16B
Shares Outstanding: 218,960,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: 87.11%
Operating Margin: -603.04%
Net Profit Margin: -579.10%
FCF Margin: -490.07%
ROA: -44.90%
ROE: -59.87%
ROIC: -50.20%
Current Ratio: 13.11
Debt-to-Equity: 0.15
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: -0.53
P/S: 32.26
P/FCF: —
P/B: 3.23
EV/EBITDA: -4.08

Growth

Rev 1Y: -18.67%
Rev 1Y Fwd Est: 1.98%
Rev 3Y (CAGR): 0.21%
Rev 5Y (CAGR): 24.39%
Rev 10Y (CAGR): 40.33%
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —

Income Statement (TTM)

Revenue: $52.05M
Gross Margin: 87.11%
Operating Expenses: $359.25M
Operating Income: -$313.91M
Net Profit: -$301.45M

Balance Sheet

EPS 5Y (CAGR)

—

EPS 10Y (CAGR)

—

Cash and Equivalents: $598.64M
Working Capital: $595.25M
Total Assets: $671.32M
Net Debt: -$519.26M
Total Liabilities: $151.28M
Total Equity: $520.04M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$238.24M
Cash Flow from Investing: -$16.86M
Cash Flow from Financing: $462.61M
Free Cash Flow: -$255.1M
Capital Expenditures: $16.86M